Biologic Therapy Market Research Report Information By Product Type (Drugs, Instruments & Kits, Services), Therapy (Monoclonal Antibodies, Vaccines, Others), By Application (Cancer, Infectious Diseases, Autoimmune Diseases, Others), By End User (Hospitals & Clinics, Specialty Centers, Research Centers) Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global Biologic Therapy Market, by Product Type

1.1.2. Global Biologic Therapy Market, by Therapy

1.1.3. Global Biologic Therapy Market, by Application

1.1.4. Global Biologic Therapy Market, by End User

1.1.5. Global Biologic Therapy Market, by Region

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.3. Market Structure

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Technique

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE

6.1. Overview

6.2. Drugs

6.3. Instruments & Kits

6.4. Services

7. GLOBAL BIOLOGIC THERAPY MARKET, BY THERAPY

7.1. Overview

7.2. Monoclonal Antibodies

7.3. Vaccines

7.4. Others

8. GLOBAL BIOLOGIC THERAPY MARKET, BY APPLICATION

8.1. Overview

8.2. Cancer

8.3. Infectious Diseases

8.4. Autoimmune Diseases

8.5. Others

9. GLOBAL BIOLOGIC THERAPY MARKET, BY END USER

9.1. Overview

9.2. Hospitals & Clinics

9.3. Specialty Centers

9.4. Research Centers

10. GLOBAL BIOLOGIC THERAPY MARKET, BY REGION

10.1. Overview

10.2. North America

10.2.1. US

10.2.2. Canada

10.3. Europe

10.3.1. Germany

10.3.2. France

10.3.3. UK

10.3.4. Italy

10.3.5. Spain

10.3.6. Rest of Europe

10.4. Asia-Pacific

10.4.1. China

10.4.2. India

10.4.3. Japan

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Rest of the World

10.5.1. Middle East

10.5.2. Africa

10.5.3. Latin America

11. COMPETITIVE LANDSCAPE

11.1. Introduction

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Biologic Therapy Market

11.5. Competitive Benchmarking

11.6. Leading Player in terms of Number of Developments in Global Biologic Therapy Market

11.7. Key Developments & Growth Strategies

11.7.1. New Product Launch

11.7.2. Merger & Acquisition

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix

11.8.1. Sales & Operating Income, 2022

11.8.2. Major Players R&D Expenditure, 2022

12. COMPANY PROFILES

12.1. Samsung Biologics

12.1.1. Company Overview

12.1.2. Financial Overview

12.1.3. TYPEs Offered

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Amgen Inc

12.3. Novo Nordisk A/S

12.4. Sanofi

12.5. Johnson & Johnson Services, Inc

12.6. Celltrion Healthcare Co., Ltd

12.7. Bristol-Myers Squibb Company

12.8. Eli Lilly and Company

12.9. F. Hoffmann La-Roche Ltd

12.10. Aeglea BioTherapuetics

13. APPENDIX

13.1. Reference Report

13.2. Related Reports

NOTE:

This table of content is tentative and subject to change as the research progresses.

 In section 12, only the top 10 companies will be profiled. Each company will be profiled based on the Market Overview, Financials, Product Portfolio, Business Strategies, and Recent Developments parameters.

 In section 12, SWOT analysis will be provided for 5 major companies.

 Please note: The financial details of the company cannot be provided if the information is not available in the public domain and or from reliable sources.

LIST OF TABLES

TABLE 1 GLOBAL BIOLOGIC THERAPY MARKET, SYNOPSIS, 2019–2032

TABLE 2 GLOBAL BIOLOGIC THERAPY MARKET, ESTIMATES & FORECAST, 2019–2032 (USD BILLION)

TABLE 3 GLOBAL BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 4 GLOBAL BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 5 GLOBAL BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 6 GLOBAL BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 7 NORTH AMERICA: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 8 NORTH AMERICA: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 9 NORTH AMERICA: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 10 NORTH AMERICA: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 11 US: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 12 US: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 13 US: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 14 US: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 15 CANADA: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 16 CANADA: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 17 CANADA: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 18 CANADA: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 19 EUROPE: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 20 EUROPE: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 21 EUROPE: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 22 EUROPE: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 23 GERMANY: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 24 GERMANY: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 25 GERMANY: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 26 GERMANY: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 27 FRANCE: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 28 FRANCE: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 29 FRANCE: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 30 FRANCE: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 31 ITALY: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 32 ITALY: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 33 ITALY: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 34 ITALY: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 35 SPAIN: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 36 SPAIN: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 37 SPAIN: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 38 SPAIN: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 39 UK: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 40 UK: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 41 UK: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 42 UK: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 43 REST OF EUROPE: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 44 REST OF EUROPE: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 45 REST OF EUROPE: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 46 REST OF EUROPE: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 47 ASIA-PACIFIC: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 48 ASIA-PACIFIC: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 49 ASIA-PACIFIC: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 50 ASIA-PACIFIC: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 51 JAPAN: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 52 JAPAN: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 53 JAPAN: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 54 JAPAN: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 55 CHINA: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 56 CHINA: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 57 CHINA: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 58 CHINA: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 59 INDIA: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 60 INDIA: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 61 INDIA: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 62 INDIA: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 63 AUSTRALIA: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 64 AUSTRALIA: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 65 AUSTRALIA: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 66 AUSTRALIA: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 67 SOUTH KOREA: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 68 SOUTH KOREA: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 69 SOUTH KOREA: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 70 SOUTH KOREA: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 71 REST OF ASIA-PACIFIC: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 72 REST OF ASIA-PACIFIC: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 73 REST OF ASIA-PACIFIC: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 74 REST OF ASIA-PACIFIC: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 75 REST OF THE WORLD: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 76 REST OF THE WORLD: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 77 REST OF THE WORLD: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 78 REST OF THE WORLD: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 79 MIDDLE EAST: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 80 MIDDLE EAST: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 81 MIDDLE EAST: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 82 MIDDLE EAST: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 83 AFRICA: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 84 AFRICA: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 85 AFRICA: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 86 AFRICA: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

TABLE 87 LATIN AMERICA: BIOLOGIC THERAPY MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 88 LATIN AMERICA: BIOLOGIC THERAPY MARKET, BY THERAPY, 2019–2032 (USD BILLION)

TABLE 89 LATIN AMERICA: BIOLOGIC THERAPY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 90 LATIN AMERICA: BIOLOGIC THERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BIOLOGIC THERAPY MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BIOLOGIC THERAPY MARKET

FIGURE 4 GLOBAL BIOLOGIC THERAPY MARKET, SHARE (%), BY PRODUCT TYPE , 2022

FIGURE 5 GLOBAL BIOLOGIC THERAPY MARKET, SHARE (%), BY THERAPY, 2022

FIGURE 6 GLOBAL BIOLOGIC THERAPY MARKET, SHARE (%), BY APPLICATION, 2022

FIGURE 7 GLOBAL BIOLOGIC THERAPY MARKET, SHARE (%), BY END USER, 2022

FIGURE 8 GLOBAL BIOLOGIC THERAPY MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 NORTH AMERICA: BIOLOGIC THERAPY MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 EUROPE: BIOLOGIC THERAPY MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 ASIA-PACIFIC: BIOLOGIC THERAPY MARKET, SHARE (%), BY REGION, 2022

FIGURE 12 REST OF THE WORLD: BIOLOGIC THERAPY MARKET, SHARE (%), BY REGION, 2022

FIGURE 13 GLOBAL BIOLOGIC THERAPY MARKET: COMPANY SHARE ANALYSIS (%), 2022

FIGURE 14 SAMSUNG BIOLOGICS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 SAMSUNG BIOLOGICS: SWOT ANALYSIS

FIGURE 16 AMGEN INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 AMGEN INC: SWOT ANALYSIS

FIGURE 18 NOVO NORDISK A/S: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 NOVO NORDISK A/S: SWOT ANALYSIS

FIGURE 20 SANOFI: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 SANOFI: SWOT ANALYSIS

FIGURE 22 JOHNSON & JOHNSON SERVICES, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 JOHNSON & JOHNSON SERVICES, INC: SWOT ANALYSIS

FIGURE 24 CELLTRION HEALTHCARE CO., LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 CELLTRION HEALTHCARE CO., LTD: SWOT ANALYSIS

FIGURE 26 BRISTOL-MYERS SQUIBB COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 BRISTOL-MYERS SQUIBB COMPANY: SWOT ANALYSIS

FIGURE 28 ELI LILLY AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 ELI LILLY AND COMPANY: SWOT ANALYSIS

FIGURE 30 F. HOFFMANN LA-ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 F. HOFFMANN LA-ROCHE LTD: SWOT ANALYSIS

FIGURE 32 AEGLEA BIOTHERAPUETICS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 AEGLEA BIOTHERAPUETICS: SWOT ANALYSIS